中山醫學大學醫學系 教授 |
||
2019 | Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., . . . Ueng, K. C., . . . Investigator, O. O. C. (2019). Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the American College of Cardiology, 74(9), 1167-1176. doi:10.1016/j.jacc.2019.03.013. [Journal Category: Cardiovascular System & Cardiology; Q1] |
|
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., . . . Ueng, K. C., . . . Investigato, O. O. C. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes & Endocrinology, 7(8), 618-628. doi:10.1016/s2213-8587(19)30158-5. [Journal Category: Endocrinology & Metabolism; Q1] |
|
|
Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Bregeault, M. F., Dalby, A. J., . . . Ueng, K. C., . . . Comm, O. O. (2019). Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial. Circulation, 140(2), 103-112. doi:10.1161/circulationaha.118.038840. [Journal Category: Cardiovascular System & Cardiology; Q1] | ||
Szarek, M., White, H. D., Schwartz, G. G., Alings, M., Bhatt, D. L., Bittner, V. A., . . . Ueng, K. C., . . . Investigator, O. O. C. (2019). Alirocumab reduces total nonfatal cardiovascular and fatal events the ODYSSEY OUTCOMES trial. Journal of the American College of Cardiology, 73(4), 387-396. doi:10.1016/j.jacc.2018.10.039. [Journal Category: Cardiovascular System & Cardiology; Q1] | ||
2018 | Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Ueng, K. C., . . . Inv, O. O. C. (2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. New England Journal of Medicine, 379(22), 2097-2107. doi:10.1056/NEJMoa1801174. [Journal Category: Medicine, General & Internal; Q1] |
|
2013 | Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., . . . Ueng, K., . . . Savor-Timi Steering Comm, I. (2013). Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. New England Journal of Medicine, 369(14), 1317-1326. doi:10.1056/NEJMoa1307684. [Journal Category: Medicine, General & Internal; Q1] |
Copyright © 2020 碩睿資訊有限公司 All Right Reserved